Consensus AstraZeneca PLC Nasdaq

Equities

AZN

US0463531089

Real-time Estimate Cboe BZX 15:33:45 13/05/2024 BST 5-day change 1st Jan Change
77.24 USD +0.08% Intraday chart for AstraZeneca PLC +2.13% +14.88%

Evolution of the average Target Price on AstraZeneca PLC

Price target over the last 5 years

History of analyst recommendation changes

a.4GnfboePp8a2cOprkA9Uo7Hs25_HPIyyfXogv6d-zPs.qju0IfXH7I3TNoFYpHU8leGLju7_W8XRHkxL_ek8hsOzDe468LrulOY2sw~20daefe9a5b1303065454d3192c26278

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
154.8 USD
Average target price
166.8 USD
Spread / Average Target
+7.72%
High Price Target
220.2 USD
Spread / Highest target
+42.24%
Low Price Target
131.3 USD
Spread / Lowest Target
-15.19%

Consensus detail

Consensus revision (last 18 months)

Analysts covering AstraZeneca PLC

Jefferies & Co.
JEFFERIES Peter Welford
BERENBERG Luisa Hector
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
JPMORGAN James Gordon
Barclays
UBS Matthew Weston
DZ BANK Elmar Kraus
alphavalue Abhishek Raval
BERNSTEIN RESEARCH Justin Smith
Deutsche Bank Securities
Bernstein
B. Riley
RBC Capital Markets
Berenberg Bank
BMO Capital
Stifel Nicolaus
CREDIT SUISSE Dominic Lunn
HSBC
Argus
Morgan Stanley
GOLDMAN SACHS Keyur Parekh
Bank of America Securities/Merrill Lynch
Danske Bank Group
Kepler Capital Markets
Kepler Cheuvreux
DEUTSCHE BANK Emmanuel Papadakis
SVB Leerink
Bryan, Garnier & Co.
Societe Generale
Liberum Capital
ODDO BHF
BANK OF AMERICA (BOFA) Sachin Jain
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings